| 10/26/06 - 11:00 AM  
 
   
 
|   #17 |
Doesn't it also say EBV will infect oropharyngeal lymphoid tissue before the viremia?
aisha2 wrote: EBV is present in oropharyngeal secretions and most commonly is transmitted through saliva. After initial inoculation, the virus replicates in nasopharyngeal epithelial cells. Cell lysis is associated with release of virions, with viral spread to contiguous structures, including salivary glands and oropharyngeal lymphoid tissues. Further viral replication results in viremia, with subsequent infection of the lymphoreticular system, including the liver, spleen, and B lymphocytes in peripheral blood. Host immune response to the viral infection includes CD8-positive T lymphocytes with suppressor and cytotoxic functions, the characteristic atypical lymphocytes found in the peripheral blood. The T lymphocytes are cytotoxic to the EBV-infected B cells and eventually reduce the number of EBV-infected B lymphocytes. To initiate cellular infection, a viral particle attaches via its major outer envelope glycoprotein, ie, gp350/220, to the EBV receptor CD21 on a B lymphocyte. SO I THINK ILL GO WITH "A" .
|
|
| |
| |